Julie A. Wickenden - Concepedia

Author

Julie A. Wickenden

Also Known As

J A Wickenden, J. A. Wickenden, J. Wickenden, Julie A Wickenden, Julie A. Wickenden, Julie Wickenden, Julie. A. Wickenden

Publications

709

Citations

H-Index

Concepts

All Affiliations

Julie A. Wickenden is an author at University of Edinburgh specializing in medicine, cell biology, and cell signaling.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	281
2	Cell Biology	3	3	281
3	Engineering	1	1	84
4	Public Health	1	1	131
5	Immunology	1	1	131

Julie A. Wickenden

Publications

597

Citations

H-Index

Page 1

	Year	Citations
ERK1/2‐dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl‐1 and Bcl‐xL Katherine Ewings, Kathryn Hadfield-Moorhouse, Ceri M. Wiggins, The EMBO Journal	2007	172
Conditional deletion of Stat3 in mammary epithelium impairs the acute phase response and modulates immune cell numbers during post‐lactational regression Katherine Hughes, Julie A. Wickenden, Judith E. Allen, The Journal of Pathology	2011	144
Cigarette Smoke Prevents Apoptosis through Inhibition of Caspase Activation and Induces Necrosis Julie A. Wickenden, Murray C.H. Clarke, Adriano G. Rossi, American Journal of Respiratory Cell and Molecular Biology Tobacco CessationInflammatory Lung DiseaseLung InflammationApoptosisImmunology	2003	131
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations Dean E. Hammond, Craig J. Mageean, Emma V. Rusilowicz, Journal of Proteome Research EngineeringCancer BiologyTumor BiologyTumor HeterogeneityCancer Cell Biology	2015	84
Colorectal cancer cells with the BRAFV600E mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM Julie A. Wickenden, Hong Ri Jin, Mark Johnson, Oncogene OncologyMedicineColorectal CancerGrowth Factor-independent SurvivalColorectal Cancer Cells	2008	66

Page 1